共 38 条
- [21] Re: Clinical Outcomes After Combined Therapy With Dutasteride Plus Tamsulosin or Either Monotherapy in Men With Benign Prostatic Hyperplasia (BPH) by Baseline Characteristics: 4-Year Results From the Randomized, Double-Blind Combination of Avodart and Tamsulosin (CombAT) Trial Editorial CommentJOURNAL OF UROLOGY, 2012, 187 (02): : 583 - 584Kaplan, Steven A.
- [22] Effect of Doxazosin Gastrointestinal Therapeutic System 4 mg vs Tamsulosin 0.2 mg on Nocturia in Chinese Men With Lower Urinary Tract Symptoms: A Prospective, Multicenter, Randomized, Open, Parallel StudyUROLOGY, 2011, 78 (03) : 636 - 640Zhang, KaiYu, WeiJin, JieYe, HaiyunWang, XiaofengZhang, NingYang, YongZhong, ChenyangWan, Ben
- [23] EFFECT OF VIBEGRON ON QUALITY OF LIFE IN MEN WITH BENIGN PROSTATIC HYPERPLASIA AND SYMPTOMS OF OVERACTIVE BLADDER: PATIENT-REPORTED OUTCOMES FROM THE PHASE 3 RANDOMIZED CONTROLLED COURAGE TRIALJOURNAL OF UROLOGY, 2024, 211 (05): : E1148 - E1149Staskin, David R.Owens-Grillo, JanetThomas, ElizabethRovner, Eric S.Cline, KevinMujais, Salim
- [24] GreenLight HPS laser 120 W vs diode laser 300 W vaporization of the prostate for the treatment of benign prostatic hyperplasia in Japanese patients: A prospective, single-center, randomized clinical trialLUTS-LOWER URINARY TRACT SYMPTOMS, 2021, 13 (01) : 31 - 37Kobayashi, TakeshiSeki, NarihitoSong, Yoo H.Dejima, Takashi
- [25] Comparison of Murraya koenigii- and Tribulus terrestris-Based Oral Formulation Versus Tamsulosin in the Treatment of Benign Prostatic Hyperplasia in Men Aged >50 Years: A Double-Blind, Double-Dummy, Randomized Controlled TrialCLINICAL THERAPEUTICS, 2011, 33 (12) : 1943 - 1952Sengupta, GairikHazra, AvijitKundu, AnupGhosh, Anirban
- [26] Men's Sexual Health Questionnaire score changes vs spontaneous sexual adverse event reporting in men treated with dutasteride/tamsulosin combination therapy for lower urinary tract symptoms secondary to benign prostatic hyperplasia: A post hoc analysis of a prospective, randomised, placebo-controlled studyINTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2020, 74 (05)Roehrborn, Claus G.Rosen, Raymond C.Manyak, Michael J.Manuel Palacios-Moreno, JuanWilson, Timothy H.Lulic, ZrinkaGiuliano, Francois
- [27] A prospective, randomized, open-label, parallel trial comparing the efficacy of α-blocker or 5α-reductase inhibitor withdrawal to continued combination therapy on the maintenance of lower urinary tract symptoms in men with benign prostatic hyperplasiaPROSTATE, 2024, 84 (04): : 403 - 413Lee, Kwang SukYoo, Jeong WooKim, Dae HoJeon, SoyoungYang, JuyeonChung, Byung HaKoo, Kyo Chul
- [28] A prospective, randomized, open-label, parallel trial comparing the efficacy of ablocker or 5a-reductase inhibitor withdrawal to continued combination therapy on the maintenance of lower urinary tract symptoms in men with benign prostatic hyperplasiaEUROPEAN UROLOGY, 2024, 85 : S1794 - S1795Bang, S.Lee, K. S.Yoo, J. W.Kim, D. H.Jeon, S.Yang, J.Chung, B. H.Koo, K. C.
- [29] Re: Comparison of Murraya koenigii- and Tribulus terrestris-Based Oral Formulation Versus Tamsulosin in the Treatment of Benign Prostatic Hyperplasia in Men Aged >50 Years: A Double-Blind, Double-Dummy, Randomized Controlled Trial Editorial CommentJOURNAL OF UROLOGY, 2012, 188 (04): : 1236 - 1237Kaplan, Steven A.
- [30] Effect of Tadalafil Once Daily on Prostate Blood Flow and Perfusion in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: A Randomized, Double-blind, Multicenter, Placebo-controlled TrialUROLOGY, 2014, 84 (02) : 412 - 419Pinggera, Germar-MichaelFrauscher, FerdinandPaduch, Darius A.Bolyakov, AlexEfros, MitchellKaminetsky, JedDa Pozzo, LuigiEsler, AnneCox, David